670 Development of a robust manufacturing process for AB-1015, an integrated circuit T cell (ICT) products, using targeted, CRISPR integration of transgenes by electroporation (CITE) editing
Mende, Ines, Tran, Ben, Chow, Kartoa, Kennedy, Mark, Kukreja, Monica, Smith, Jenessa B, Wang, Haixia, Dibian, Zain, Ha, Elisa, McRae, Tejon, Nguyen, Tanya, Saephan, Tommy, Clagett, Erin, Lang, Nathan, Lim, Raymond, Wu, Jason, Chang, Alice, Guiang, Liselle, Guner, Nadija, Gunturu, Swetha, Huang, Elizabeth, Lalchandani, Aditya, Lee, Max, Phillips, Sophia, Chang, Stephen, Chu, Eric, Zapata, Ryan, Chang, En-Hsiang, Dai, Rory, Kandarian, Fadi, Ko, Hayden, Nguyen, Anton, Nie, Wendy, Parikh, Kathan, Rios, Lindsay, Sun, Xiangle, Tran, Stella, Holman, Peter, Sirichoke, Tim
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article